Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Buys Facility for $14M

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific has purchased a building that it had been leasing in Franklin, Mass., for around $14 million, according to real estate transaction tracker CoStar Group.
The property is a 110,756-square-foot, one-story industrial building that sits on nearly 17 acres of land.
Thermo bought the property from Embarcadero Capital.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.